Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $2.70 | Change: $-0.06 | %Change: -2.17%
Volume: 14,516 | Day High/Low: 2.76/2.70 | 52 Week High/Low: 5.73/1.35


View modes: 
2.5 stars

RE:Q4 and Year End Results

It's a solid report much along the lines that I had expected. Burn rate is modest and we still have $12.5 million in cash with several milestone payments due this quarter and next. The litigation...read more
3.5 stars

Q4 and Year End Results

my CNW   Nuvo Research Inc.   Transmitted by CNW Group on : February 20, 2014 17:00   Nuvo Research announces 2013 fourth quarter & year-end results MISSISSAUGA, ON, Feb. 20, 2014 /CNW/ - Nuvo...read more
4 stars

RE:The good ol' days and Mark Bartlett request

were truer words ever spoken than Stockietalkie's assessment of the management? As a member of the original "group of 12" I still hope that somehow you guys are able to recoup some of your losses in...read more
3.5 stars

RE:RE:Remebering Voltaren, Pennsaid 2% takes the Challenge

Stockie: Many Americans actually buy their Voltaren online from Canada as most insurers do not cover it and the cost in the US is between $40-$100 a tube. http://orthopedics.answers.com/diagnosis...read more
1 star

More $ to come

My opinion:  the next year will be profitable  for Nuvo. Pennsaid 2% is a winner product, a good leader. The sales will raise, stay optimistic. There's no brainer in front of us just be patient as we...read more
3 stars

RE:Remebering Voltaren, Pennsaid 2% takes the Challenge

Schaf, You need to keep in mind that Voltaren in the US is not OTC, whereas in Canada it is. I believe that pricing is not the same in the US, and that is the territory we need to watch closely.  2...read more
1 star

RE:The good ol' days and Mark Bartlett request

Thanks Stockie  rate and reply
5 stars

RE:Remebering Voltaren, Pennsaid 2% takes the Challenge

I don't disagree with anything that you have said Schaffaussen. I like the price comparison using product size and dousing. What I am looking for is some good old fashion retail advertising - print...read more
5 stars

Remebering Voltaren, Pennsaid 2% takes the Challenge

In the past we often discussed Pennsaid original with relation to Voltaren in the hopes that Pennsaid original would be able to take away much of Voltaren's majority topical NSAID market share. Also...read more
5 stars

RE:The good ol' days and Mark Bartlett request

Thanks Stockie, I've read quite a few of your posts over the years and you have posted many insightful and knowledgeable facts that may educate an unprofessional share holder like myself. It would be...read more
3 stars

The good ol' days and Mark Bartlett request

DJ,  in order for NUVO to reach $14.80 (our highest share price ever) pre-split, you would need to see the current share price at 65x $14.80 = $962 in today's price.......so if you are betting, I...read more
4.5 stars

The Good Old Days

Does anybody here remember when this Stock soared to $14 plus just on the speculation that Canadian approval was just around the bend. I have friends and Aquaintenances that were dreaming about what...read more
3 stars

RE:cup and handle

Matt Collins - is that you? Good to see you posting again your nonsensical posts always cheer me up.  rate and reply
5 stars

RE:cup and handle

Your cup looks to have sprung a leak this morning. Nevertheless this is a character building day for Nuvo. We sold off but held $3.00 early on. There are a lot of shares to sell before we can get...read more
5 stars

RE:wow...climing into the close....$3.24 RTQ!!!

phil,you are so smart ,you always seem to post the most inteligent things to say on this board,who has ever scored such high marks as you on three posts back to back to back all within three hours...read more
4.5 stars

cup and handle

any other chartists out there see this recent move as a breakout from a longer term cup and handle formation? if so, i posit we will see this move take the stock northward of $6.00  rate and reply
3 stars

$3.26 RTQ and climbing....volume growing

looks like run has started.  yes delayed from when it should have been, but nevertheless stared.  rate and reply
3 stars

wow...climing into the close....$3.24 RTQ!!!

bids chasing the sasks now.  rate and reply
1 star

RE:RE:In other MNK news

My bad. I only checked Google and Yahoo finance, as well as the New York Times Financial page. Looks like the release didn't exactly receive a lot of coverage.  rate and reply
5 stars

RE:In other MNK news

Yes Mallinckrodt has acknowledged approval and even updated the Pennsaid website http://www.pennsaid.com to reflect the new product.  rate and reply